GSMS Incorporated, 1,000 MG recall — Golden State Medical Supply Inc. (Class II)
Golden State Medical Supply Inc. is recorded by the U.S. Food and Drug Administration (FDA) as recalling GSMS Incorporated, 1,000 MG — a Class II recall, initiated 2026-05-29 and posted to the FDA enforcement report on 2026-06-17, under recall number D-0587-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.”. From the product description, the form is extended-release tablets, the strength given is 1,000 MG, the package is described as 90 tablets and it is marked Rx only. 1 National Drug Code number is printed in the record: 51407-268-90. Distribution is recorded as “Within the U.S Market”, with the recalling firm on record in CA, United States. It is the only recall number the FDA has filed under event ID 99127. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0587-2026 |
|---|---|
| FDA event ID | 99127 |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Golden State Medical Supply Inc. |
| Recall initiated | 2026-05-29 |
| Reported by FDA | 2026-06-17 |
| Report lag | 19 days from initiation to report |
| Distribution | Within the U.S Market. |
| Firm location on record | CA, United States |
| Product description (source) | GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90. |
Reason reported by FDA
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
23 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
5 identifying values matched by exact pattern in the 35-word product description above; each is a literal substring of it.
| Product named | GSMS Incorporated |
|---|---|
| Form | Extended-Release Tablets |
| Strength | 1,000 MG |
| Package | 90 tablets |
| NDC | 51407-268-90 |
| Marketing category | Rx only |
Other indexed recalls from Golden State Medical Supply Inc.
3 indexed records name Golden State Medical Supply Inc. as the recalling firm, across 2 FDA events, reported 2026-05-27 to 2026-06-17. A coverage-limited activity count over the ingested window, not a quality rating.
| Recall record | Recall number | FDA tier | Strength / form | Reported |
|---|---|---|---|---|
| Primidone Tablets, 50 mg | D-0534-2026 | Class III | 50 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 250 mg | D-0535-2026 | Class III | 250 mg · Tablets | 2026-05-27 |
Reported in the same month (2026-06)
74 enforcement reports carry a report date in 2026-06; these 8 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Duloxetine Delayed-Release Capsules, 30mg | D-0582-2026 | Breckenridge Pharmaceutical, Inc. | Class II | 2026-06-17 |
| Duloxetine Delayed-Release Capsules, 60mg | D-0583-2026 | Breckenridge Pharmaceutical, Inc. | Class II | 2026-06-17 |
| Zep, 70% | D-0586-2026 | Zep Inc | Class II | 2026-06-17 |
| Minocycline Hydrochloride Extended-Release Tablets, 115 mg | D-0597-2026 | Ascend Laboratories, LLC | Class II | 2026-06-17 |
| Budesonide Inhalation Suspension, 1mg/2mL | D-0607-2026 | Sun Pharmaceutical Industries Inc | Class II | 2026-06-17 |
| Lidocaine HCl Injection USP | D-0554-2026 | Spectra Medical Devices, LLC | Class II | 2026-06-10 |
| Duloxetine DR Capsules, 30 mg | D-0555-2026 | Asclemed Usa Inc. | Class II | 2026-06-10 |
| Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg | D-0556-2026 | Ascend Laboratories, LLC | Class II | 2026-06-10 |
Nearest Class II recalls by date
213 of 250 indexed records share the Class II tier; the 6 nearest to 2026-06-17 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| KIRKLAND Signature, 1000 mg | D-0557-2026 | Guardian Drug Co. Inc. | 1000 mg | 2026-06-10 |
| HALEON CALCIUM CARBONATE TUMS ANTACID, 1000 mg | D-0558-2026 | Guardian Drug Co. Inc. | 1000 mg · Tablets | 2026-06-10 |
| HALEON CALCIUM CARBONATE TUMS ANTACID, 750 mg | D-0559-2026 | Guardian Drug Co. Inc. | 750 mg · Tablets | 2026-06-10 |
| Good Neighbor Pharmacy, 750 mg | D-0560-2026 | Guardian Drug Co. Inc. | 750 mg | 2026-06-10 |
| Good Neighbor Pharmacy, 1000 mg | D-0561-2026 | Guardian Drug Co. Inc. | 1000 mg · Chewable Tablets | 2026-06-10 |
| Extra strength Antacid Calcium Carbonate 750 mg | D-0562-2026 | Guardian Drug Co. Inc. | 750 mg · Chewable Tablets | 2026-06-10 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 51407-268-90 at the FDA source to confirm it is covered.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Golden State Medical Supply Inc. (3 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0587-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0587-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-06-17
- Ingested
- 2026-08-22
- Record hash
52942a5111e76dfc
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.